Clinical Trial Update: Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of duloxetine versus placebo and pelvic floor muscle training in subjects with stress urinary incontinence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Duloxetine (Cymbalta) (Duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Urinary Stress Incontinence | Phase 2 | Status: COMPLETED